Reply: Important molecular differences between therapeutic interleukin-6 receptor inhibition and its genetic mimicry in AD patients

Research output: Contribution to journalCommentary/debatepeer-review

Original languageEnglish
JournalJournal of Allergy and Clinical Immunology
Publication statusAccepted/In press - 12 Sept 2024

Cite this